2009-10-21 07:27:40 -
The global aesthetic devices market is forecast to grow from $2.4 billion in 2008 to $4 billion in 2015 with an annual growth rate of 7.9%. The aesthetic devices market is driven by product innovation, a growing demand for aesthetic procedures among all age groups, an expanding non-core physician base and Direct to Consumer (DTC) approach of companies like Allergan, Solta Medical etc.
Silicone breast implants and hyaluronic acid markets accounted for 35.7% of the overall aesthetic devices market in 2008 and are expected to account for
44.7% in 2015. The silicone breast implant market is forecast to grow by 13% annually for the next seven years to reach $1 billion in 2015. Hyaluronic acid is forecast to grow by 9.5% annually for the next seven years to reach $756.8 m in 2015.
The key factors driving growth in the silicone breast implants market are the US FDA approval of silicone breast implants in 2006, reduction in procedure costs due to a healthy competition between core and non-core physicians and an increasing patient demand. Growth in the hyaluronic acid market will be driven by its inherent advantage of shorter procedure time and an increasing patient demand.
In the US, by the end of 2007, silicone breast implants had a 30% contribution towards the overall breast implants market and by the end of 2008, the contribution increased to 45%. According to Global Markets Direct’s forecast for 2008 - 2015, the silicone breast implants market is expected to contribute 90% towards the overall US breast implants market.
In the US, prior to 2006, saline breast implants were the only breast implants approved by the FDA. The approval of silicone breast implants by the US FDA in 2006, resulted in a reduction of the market size for saline breast implants, in a short span of two years.
The US breast implants market is dominated by Allergan, Inc. and Johnson & Johnson with a market share of 46% and 54% respectively. Sientra is another company which is in the process of successfully completing clinical trials for a new range of silicone breast implants to be marketed in the US. Allergan and Johnson & Johnson have a combined market share of 67.3% in the European breast implants market. Sientra and Medicor are other key players in the European breast implants market.
For more information click below:
www.globalmarketsdirect.com/Report.aspx?ID=The-Future-of-the-Aes ..
A new report by Global Markets Direct, the business intelligence specialists, finds that increasing patient demand for aesthetic procedures and innovation are expected to drive the global aesthetics devices market. Global Markets Direct’s report, “The Future of the Aesthetic Devices Market to 2015”, highlights these developments as the key market drivers for the global aesthetic devices market.
For more information click below:
www.globalmarketsdirect.com/Report.aspx?ID=The-Future-of-the-Aes ..
Or
Visit our report store:
www.globalmarketsdirect.com 
